FXTAS presenting with cervical dystonia as the initial symptom: Considering FXTAS in the clinical evaluation of cervical dystonia [PDF]
FXTAS (Fragile X-associated tremor/ataxia syndrome) is characterized by typical clinical features, including tremor, cerebellar ataxia, parkinsonism, and the middle cerebellar peduncle (MCP) sign, which appears as T2 hyperintensity in the MCP on MRI ...
Homare Funasaka +2 more
doaj +5 more sources
Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS? [PDF]
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a severe neurodegenerative movement disorder affecting over 40% of male and 16% of female FMR1 premutation carriers over the age of 50.
Annie L Shelton +2 more
exaly +4 more sources
New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
Purpose: Fragile X-associated tremor/ataxia syndrome (FXTAS) was originally defined as tremor, ataxia, cognitive decline and parkinsonism in individuals who carry between 55-200 CGG repeats in the promoter region of the fragile X mental retardation 1 ...
Padmaja Vittal +2 more
exaly +4 more sources
Current Gaps in Understanding the Molecular Basis of FXTAS
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder with defining clinical features that include kinetic tremor, gait ataxia, and parkinsonism, with associated features spanning medical, cognitive, and psychiatric ...
Paul J. Hagerman
doaj +7 more sources
Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) [PDF]
The course of pathophysiological mechanisms involved in fragile X-associated tremor/ataxia syndrome (FXTAS) remains largely unknown. Previous proteomics and metabolomics studies conducted in blood samples collected from FMR1 premutation carriers with ...
Maria Jimena Salcedo-Arellano +2 more
exaly +4 more sources
Emerging topics in FXTAS [PDF]
This paper summarizes key emerging issues in fragile X-associated tremor/ataxia syndrome (FXTAS) as presented at the First International Conference on the FMR1 Premutation: Basic Mechanisms & Clinical Involvement in 2013.
Hall, DA +11 more
openaire +9 more sources
T2-FLAIR hyperintensities in the inferior cerebellar peduncles and their association with clinical symptoms, molecular and MRI markers in male FMR1 premutation carriers [PDF]
Background and objectivesFMR1 premutation carriers (55–200 CGG repeats) are at risk of developing fragile X-associated tremor/ataxia syndrome (FXTAS), a neurodegenerative disorder associated with motor and cognitive impairment. Bilateral hyperintensities
Andrea Elias-Mas +16 more
doaj +2 more sources
Biomarkers of balance and gait deficits in FMR1 premutation carriers: a mini-review [PDF]
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a premutation (PM) of the FMR1 gene on the X chromosome. FXTAS is characterized by intention tremor, ataxia, and cognitive decline.
Leila C. Moore +3 more
doaj +2 more sources
Integrated multi-omics profiling reveals novel molecular biomarkers and pathways associated with Fragile X-associated tremor/ataxia syndrome [PDF]
IntroductionFragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting carriers of premutation expansions (55–200 CGG repeats) in the fragile X messenger ribonucleoprotein 1 (FMR1) gene.
Marwa Zafarullah +9 more
doaj +2 more sources
Methadone use in a male with the FMRI premutation and FXTAS [PDF]
The fragile X‐associated tremor ataxia syndrome (FXTAS) is caused by the premutation in FMR1 gene. Recent reports of environmental toxins appear to worsen the progression of FXTAS. Here we present a case of male adult with FXTAS and a long history of methadone use.
Muzar, Zukhrofi +6 more
openaire +6 more sources

